2,200
Participants
Start Date
April 30, 2018
Primary Completion Date
October 30, 2020
Study Completion Date
June 30, 2021
V160
V160 was administered as a 0.5 mL (100 Units/0.5 mL dose with Merck aluminum phosphate adjuvant \[MAPA\], 4°C stable formulation) IM injection.
Placebo
Saline solution administered as a 0.5 mL IM injection
Holdsworth House Medical Practice ( Site 0241), Sydney
Paratus Clinical Pty Ltd - Blacktown Clinic ( Site 0247), Blacktown
Paratus Clinical Kanwal - Trial Clinic ( Site 0243), Kanwal
University of the Sunshine Coast Clinical Trials Centre ( Site 0244), Morayfield
University of the Sunshine Coast Clinical Trials Centre ( Site 0245), Sippy Downs
Mid Hudson Medical Research ( Site 0294), New Windsor
Hospital Clinico Universitario de Santiago ( Site 0151), Santiago de Compostela
Emerson Clinical Research Institute ( Site 0297), Washington D.C.
Turku Vaccine Research Center ( Site 0183), Turku
University of Maryland School of Medicine ( Site 0041), Baltimore
National Clinical Research-Richmond, Inc. ( Site 0051), Richmond
Clinical Research Associates of Tidewater ( Site 0056), Norfolk
York Clinical Research, LLC ( Site 0033), Norfolk
Health Research of Hampton Roads, Inc. ( Site 0014), Newport News
PMG Research of Raleigh, LLC ( Site 0048), Raleigh
Carolina Women's Research and Wellness Center ( Site 0035), Durham
Hospital Universitario 12 de Octubre ( Site 0152), Madrid
Hospital Universitario La Paz ( Site 0157), Madrid
Pori Vaccine Research Center ( Site 0182), Pori
PMG Research of Wilmington ( Site 0006), Wilmington
Coastal Pediatric Research ( Site 0010), Charleston
Coastal Carolina Research Center ( Site 0053), Mt. Pleasant
Palmetto Clinical Research ( Site 0289), Summerville
Parkside Pediatric ( Site 0288), Greenville
Columbus Regional Research Institute ( Site 0298), Columbus
Care Partners Clinical Research, LLC ( Site 0002), Jacksonville
Clinical Associates of Orlando, LLC ( Site 0032), Orlando
Indago Research & Health Center, Inc ( Site 0007), Hialeah
NF Research Center LLC ( Site 0013), Hialeah
Best Quality Research Inc. ( Site 0031), Hialeah
Tampereen yliopisto Rokotetutkimuskeskus ( Site 0181), Tampere
Clinical Research of South Florida ( Site 0047), Coral Gables
L&C Professional Medical Research Institute ( Site 0021), Miami
Advanced Medical Research Institute ( Site 0296), Miami
Kendall South Medical Center, Inc ( Site 0008), Miami
New Age Medical Research Corporation ( Site 0018), Miami
Alabama Clinical Therapeutics ( Site 0025), Birmingham
Achieve Clinical Research, LLC ( Site 0055), Birmingham
Senders Pediatrics ( Site 0060), Cleveland
Rapid Medical Research, Inc. ( Site 0038), Cleveland
Cincinnati Children's Hospital Medical Center ( Site 0003), Cincinnati
Seinajoki Vaccine Research Center ( Site 0189), Seinäjoki
Heartland Research Associates, LLC ( Site 0044), Augusta
Tampereen yliopisto Kokkolan rokotetutkimusklinikka ( Site 0190), Kokkola
Heartland Research Associates, LLC ( Site 0023), Newton
Heartland Research Associates, LLC ( Site 0019), Wichita
ACC Pediatric Research ( Site 0022), Haughton
Lynn Health Science Institute ( Site 0287), Oklahoma City
Radiant Research - Dallas ( Site 0045), Dallas
Juno Research, LLC ( Site 0293), Houston
Accurate Clinical Management, LLC ( Site 0028), Pasadena
Crossroads Clinical Research LLC ( Site 0283), Victoria
Diagnostics Research Group ( Site 0001), San Antonio
Synexus Research ( Site 0058), San Antonio
Coastal Bend Clinical Research ( Site 0299), Corpus Christi
Tekton Research, Inc. ( Site 0036), Austin
Synexus US Phoenix Southeast ( Site 0057), Chandler
Albuquerque Clinical Trials ( Site 0052), Albuquerque
Tampereen yliopisto Oulun rokotetutkimusklinikka ( Site 0187), Oulu
Bayview Research Group, LLC ( Site 0012), Valley Village
California Research Foundation ( Site 0286), San Diego
Inland Empire Liver Foundation ( Site 0026), Rialto
Integrated Research of Inland, Inc. ( Site 0042), Riverside
Diablo Clinical Research, Inc ( Site 0009), Walnut Creek
Multicare / Rockwood Clinic ( Site 0034), Spokane
Premier Clinical Research Group ( Site 0050), Spokane
City Clinical Hospital 13 of Moscow ( Site 0232), Moscow
Antenatal clinic #22 ( Site 0225), Saint Petersburg
Limited Liability Company Medical Centre Aibolit ( Site 0229), Kazan'
LLC Scientific Research Medical Complex Your Health. ( Site 0230), Kazan'
Central City Hospital 7 ( Site 0237), Yekaterinburg
Siberian State Medical University ( Site 0231), Tomsk
Western Galilee Hospital ( Site 0212), Nahariya
Sakhnin west neighbourhood ( Site 0211), Sakhnin
Rambam Medical Center - Health Care Campus ( Site 0219), Haifa
Meir MC ( Site 0213), Kfar Saba
Rabin Medical Center ( Site 0218), Petah Tikva
Sourasky Medical Center ( Site 0217), Tel Aviv
Maccabi Healthcare Services ( Site 0220), Tel Aviv
Hadassah Ein Kerem Medical Center ( Site 0216), Jerusalem
St Michaels Med Center ( Site 0285), Newark
University of Texas Medical Branch at Galveston ( Site 0049), Galveston
Vaccine Evaluation Center ( Site 0264), Vancouver
PrimeHealth Clinical Research ( Site 0070), Toronto
Clinique OVO ( Site 0067), Montreal
McGill University Health Centre - Vaccine Study Centre ( Site 0064), Pierrefonds
CHUQ - Unite de Recherche en Sante Publique ( Site 0065), Québec
Diex Recherche Quebec Inc ( Site 0069), Québec
Diex Recherche Sherbrooke Inc. ( Site 0066), Sherbrooke
Diex Recherche Victoriaville Inc. ( Site 0068), Victoriaville
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0186), Espoo
Tampereen yliopisto Etela-Helsingin Rokotetutkimusklinikka ( Site 0188), Helsinki
Ita-Helsingin Rokotetutkimuskeskus ( Site 0184), Helsinki
Jarvenpaan rokotetutkimuskeskus ( Site 0185), Järvenpää
Hospital Clinic de Barcelona ( Site 0155), Barcelona
Merck Sharp & Dohme LLC
INDUSTRY